LXRX icon

Lexicon Pharmaceuticals
LXRX

Overview Fund Activity

123 hedge funds and large institutions have $626M invested in Lexicon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 47 increasing their positions, 19 reducing their positions, and 13 closing their positions.

Holders
123
Holders Change
+19
Holders Change %
+18.27%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
33
Increased
47
Reduced
19
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AG
1
Artal Group
Luxembourg
$366M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$97.4M
3
UBS AM
3
UBS AM
Illinois
$31.3M
4
MCM
4
Masters Capital Management
Georgia
$7.28M
5
NMC
5
NEA Management Company
Maryland
$15.2M

Top Sellers

1
Norges Bank
1
Norges Bank
Norway
$1.12M
2
TC
2
TFS Capital
Pennsylvania
$0
3
TRCT
3
Tower Research Capital (TRC)
New York
$0
4
GF
4
Gabelli Funds
New York
$319K
5
Citadel Advisors
5
Citadel Advisors
Florida
$41K
Name Holding Trade Value Shares
Change 		Shares
Change %
GCIA
126
Gabelli & Co Investment Advisers
New York
– -$21K -2,143 Closed
RCM
127
Rotella Capital Management
Washington
– -$19K -1,943 Closed
BNP Paribas Financial Markets
128
BNP Paribas Financial Markets
France
– -$19K -1,921 Closed
PPA
129
Parametric Portfolio Associates
Washington
– -$16K -1,618 Closed
WAM
130
World Asset Management
Michigan
– -$15K -1,570 Closed
WS
131
Wedbush Securities
California
– -$14K -1,429 Closed
Ameriprise
132
Ameriprise
Minnesota
– -$7K -749 Closed
2 3 4 5
6